bird-20230930
2023Q312-310001653909FALSEP2DP3D00016539092023-01-012023-09-300001653909us-gaap:CommonClassAMember2023-11-01xbrli:shares0001653909us-gaap:CommonClassBMember2023-11-0100016539092023-09-30iso4217:USD00016539092022-12-310001653909us-gaap:CommonClassAMember2022-12-31iso4217:USDxbrli:shares0001653909us-gaap:CommonClassAMember2023-09-300001653909us-gaap:CommonClassBMember2022-12-310001653909us-gaap:CommonClassBMember2023-09-3000016539092023-07-012023-09-3000016539092022-07-012022-09-3000016539092022-01-012022-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-06-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-06-300001653909us-gaap:AdditionalPaidInCapitalMember2022-06-300001653909us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001653909us-gaap:RetainedEarningsMember2022-06-3000016539092022-06-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-07-012022-09-300001653909us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-07-012022-09-300001653909us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001653909us-gaap:RetainedEarningsMember2022-07-012022-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-09-300001653909us-gaap:AdditionalPaidInCapitalMember2022-09-300001653909us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001653909us-gaap:RetainedEarningsMember2022-09-3000016539092022-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-06-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-06-300001653909us-gaap:AdditionalPaidInCapitalMember2023-06-300001653909us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001653909us-gaap:RetainedEarningsMember2023-06-3000016539092023-06-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-07-012023-09-300001653909us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-07-012023-09-300001653909us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001653909us-gaap:RetainedEarningsMember2023-07-012023-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-09-300001653909us-gaap:AdditionalPaidInCapitalMember2023-09-300001653909us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001653909us-gaap:RetainedEarningsMember2023-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-12-310001653909us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-12-310001653909us-gaap:AdditionalPaidInCapitalMember2021-12-310001653909us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001653909us-gaap:RetainedEarningsMember2021-12-3100016539092021-12-310001653909us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-01-012022-09-300001653909us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-01-012022-09-300001653909us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300001653909us-gaap:RetainedEarningsMember2022-01-012022-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-12-310001653909us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-12-310001653909us-gaap:AdditionalPaidInCapitalMember2022-12-310001653909us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001653909us-gaap:RetainedEarningsMember2022-12-310001653909us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-01-012023-09-300001653909us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001653909us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-01-012023-09-300001653909us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001653909us-gaap:RetainedEarningsMember2023-01-012023-09-300001653909srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2022-07-012022-09-300001653909srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2022-01-012022-09-30bird:segment0001653909srt:MinimumMember2023-01-012023-09-300001653909srt:MaximumMember2023-01-012023-09-3000016539092023-10-012023-09-3000016539092022-10-012022-09-300001653909country:US2023-07-012023-09-300001653909country:US2022-07-012022-09-300001653909country:US2023-01-012023-09-300001653909country:US2022-01-012022-09-300001653909us-gaap:NonUsMember2023-07-012023-09-300001653909us-gaap:NonUsMember2022-07-012022-09-300001653909us-gaap:NonUsMember2023-01-012023-09-300001653909us-gaap:NonUsMember2022-01-012022-09-300001653909bird:ProfessionalFeesAndOtherRelatedChargesMember2023-06-300001653909bird:SeveranceAndOtherEmployeeRelatedBenefitsMember2023-06-300001653909bird:ProfessionalFeesAndOtherRelatedChargesMember2023-07-012023-09-300001653909bird:SeveranceAndOtherEmployeeRelatedBenefitsMember2023-07-012023-09-300001653909bird:ProfessionalFeesAndOtherRelatedChargesMember2023-09-300001653909bird:SeveranceAndOtherEmployeeRelatedBenefitsMember2023-09-300001653909bird:ProfessionalFeesAndOtherRelatedChargesMember2022-12-310001653909bird:SeveranceAndOtherEmployeeRelatedBenefitsMember2022-12-310001653909bird:ProfessionalFeesAndOtherRelatedChargesMember2023-01-012023-09-300001653909bird:SeveranceAndOtherEmployeeRelatedBenefitsMember2023-01-012023-09-300001653909us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbird:AllbirdsSouthKoreaLLCMember2023-09-050001653909us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbird:AllbirdsSouthKoreaLLCMember2023-09-052023-09-05bird:installment0001653909us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbird:AllbirdsSouthKoreaLLCMember2023-07-012023-09-300001653909us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbird:AllbirdsSouthKoreaLLCMember2023-01-012023-09-300001653909us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbird:AllbirdsCanadaULCMember2023-09-190001653909us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbird:AllbirdsCanadaULCMember2023-09-192023-09-190001653909us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbird:AllbirdsCanadaULCMember2023-01-012023-09-300001653909us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbird:AllbirdsCanadaULCMember2023-07-012023-09-300001653909us-gaap:LeaseholdImprovementsMember2023-09-300001653909us-gaap:LeaseholdImprovementsMember2022-12-310001653909us-gaap:FurnitureAndFixturesMember2023-09-300001653909us-gaap:FurnitureAndFixturesMember2022-12-310001653909us-gaap:SoftwareDevelopmentMember2023-09-300001653909us-gaap:SoftwareDevelopmentMember2022-12-310001653909us-gaap:MachineryAndEquipmentMember2023-09-300001653909us-gaap:MachineryAndEquipmentMember2022-12-310001653909us-gaap:ComputerEquipmentMember2023-09-300001653909us-gaap:ComputerEquipmentMember2022-12-310001653909bird:NaturalFiberWeldingIncMember2020-11-200001653909us-gaap:SeriesAPreferredStockMemberbird:NaturalFiberWeldingIncMember2020-11-200001653909bird:NaturalFiberWeldingIncMember2023-01-012023-09-300001653909bird:NaturalFiberWeldingIncMember2023-07-012023-09-300001653909bird:NoHoESGIncMember2021-11-220001653909bird:NoHoESGIncMember2023-04-012023-04-300001653909bird:NoHoESGIncMember2023-01-012023-09-300001653909us-gaap:IntellectualPropertyMember2020-01-012020-01-3100016539092020-01-012020-01-310001653909us-gaap:FairValueMeasurementsRecurringMember2023-09-300001653909us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001653909us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001653909us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001653909us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001653909us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001653909us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001653909us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001653909us-gaap:RevolvingCreditFacilityMemberbird:CreditAgreementMember2019-02-200001653909us-gaap:RevolvingCreditFacilityMemberbird:SecondAmendmentMember2019-02-200001653909us-gaap:RevolvingCreditFacilityMemberbird:SecondAmendmentMember2023-04-17xbrli:pure0001653909us-gaap:RevolvingCreditFacilityMemberbird:SecondAmendmentMember2023-04-172023-04-170001653909us-gaap:RevolvingCreditFacilityMemberbird:CreditAgreementMemberbird:SecuredOvernightFinancingRateSOFRMember2023-01-012023-09-300001653909us-gaap:RevolvingCreditFacilityMemberbird:BaseSOFROrCommitmentFeeMembersrt:MinimumMemberbird:CreditAgreementMember2023-01-012023-09-300001653909us-gaap:RevolvingCreditFacilityMemberbird:BaseSOFROrCommitmentFeeMemberbird:CreditAgreementMembersrt:MaximumMember2023-01-012023-09-300001653909us-gaap:RevolvingCreditFacilityMemberbird:CreditAgreementMember2023-01-012023-09-300001653909us-gaap:RevolvingCreditFacilityMemberbird:CreditAgreementMember2022-12-310001653909us-gaap:RevolvingCreditFacilityMemberbird:CreditAgreementMember2023-09-30bird:classbird:vote0001653909srt:MinimumMember2023-09-300001653909srt:MaximumMember2023-09-300001653909bird:A2015EquityIncentivePlanMember2023-09-300001653909bird:A2015EquityIncentivePlanMember2022-12-310001653909bird:A2021EquityIncentivePlanMember2023-09-300001653909bird:A2021EquityIncentivePlanMember2022-12-310001653909bird:A2021EquityIncentivePlanMemberus-gaap:RestrictedStockUnitsRSUMember2023-09-300001653909bird:A2021EquityIncentivePlanMemberus-gaap:RestrictedStockUnitsRSUMember2022-12-310001653909bird:A2021EquityIncentivePlanMemberus-gaap:PerformanceSharesMember2023-09-300001653909bird:A2021EquityIncentivePlanMemberus-gaap:PerformanceSharesMember2022-12-310001653909bird:A2021EmployeeStockPurchasePlanMember2023-09-300001653909bird:A2021EmployeeStockPurchasePlanMember2022-12-310001653909bird:CommonStockWarrantsMember2023-09-300001653909bird:CommonStockWarrantsMember2022-12-310001653909bird:CommonStockWarrantsMember2022-07-012022-09-300001653909bird:CommonStockWarrantsMember2022-01-012022-09-3000016539092018-11-192018-11-190001653909us-gaap:NotesPayableOtherPayablesMember2018-11-190001653909bird:A2021EquityIncentivePlanMember2021-09-012021-09-300001653909bird:A2021EquityIncentivePlanMemberus-gaap:CommonClassAMember2021-09-012021-09-300001653909bird:A2021EmployeeStockPurchasePlanMemberus-gaap:EmployeeStockMember2021-09-012021-09-300001653909bird:A2021EmployeeStockPurchasePlanMemberus-gaap:EmployeeStockMember2021-09-300001653909bird:A2021EmployeeStockPurchasePlanMemberus-gaap:EmployeeStockMemberus-gaap:CommonClassAMember2021-09-012021-09-3000016539092022-01-012022-12-310001653909us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001653909us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001653909us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001653909us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001653909us-gaap:EmployeeStockMemberus-gaap:SubsequentEventMember2023-05-032023-11-020001653909us-gaap:EmployeeStockMember2022-11-032023-05-020001653909us-gaap:EmployeeStockMember2022-05-032022-11-020001653909us-gaap:EmployeeStockMember2021-11-032022-05-020001653909bird:ShareBasedPaymentArrangementNewEmployeesMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001653909us-gaap:RestrictedStockUnitsRSUMemberbird:ShareBasedPaymentArrangementExistingEmployeesMember2023-01-012023-09-300001653909us-gaap:RestrictedStockUnitsRSUMember2022-12-310001653909us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001653909us-gaap:RestrictedStockUnitsRSUMember2023-09-300001653909us-gaap:PerformanceSharesMember2022-05-012022-05-310001653909us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:PerformanceSharesMember2022-05-012022-05-310001653909us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMember2022-05-012022-05-310001653909us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2022-05-012022-05-310001653909srt:MinimumMemberus-gaap:PerformanceSharesMember2022-05-012022-05-310001653909srt:MaximumMemberus-gaap:PerformanceSharesMember2022-05-012022-05-310001653909us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:RestrictedStockUnitsRSUMember2023-09-300001653909us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:RestrictedStockUnitsRSUMember2023-09-300001653909us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2023-09-300001653909us-gaap:PerformanceSharesMember2023-01-012023-09-300001653909us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:PerformanceSharesMember2023-01-012023-09-300001653909us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMember2023-01-012023-09-300001653909us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2023-01-012023-09-300001653909us-gaap:PerformanceSharesMember2023-07-012023-09-300001653909us-gaap:PerformanceSharesMember2022-07-012022-09-300001653909us-gaap:PerformanceSharesMember2022-01-012022-09-300001653909us-gaap:PerformanceSharesMember2022-04-302022-04-300001653909us-gaap:PerformanceSharesMember2022-12-310001653909us-gaap:PerformanceSharesMember2023-09-3000016539092023-07-252023-07-25bird:lawsuit0001653909us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001653909us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001653909bird:CommonStockWarrantsMember2023-01-012023-09-300001653909bird:CommonStockWarrantsMember2022-01-012022-09-300001653909us-gaap:EmployeeStockMember2023-01-012023-09-300001653909us-gaap:EmployeeStockMember2022-01-012022-09-300001653909us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001653909us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001653909us-gaap:PerformanceSharesMember2023-01-012023-09-300001653909us-gaap:PerformanceSharesMember2022-01-012022-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For transition period from         to
Commission File Number 001-40963
Allbirds, Inc.
(Exact name of registrant as specified in its charter)
Delaware47-3999983
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)
730 Montgomery Street
San Francisco, CA 94111
(628) 225-4848
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Class A Common Stock, $0.0001 par value per shareBIRDThe Nasdaq Global Select Market
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No
As of November 1, 2023, the number of shares of the registrant’s Class A common stock outstanding was 100,303,748 and the number of shares of the registrant’s Class B common stock outstanding was 52,547,761.




TABLE OF CONTENTS
Page



Table of Contents
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which statements involve substantial risk and uncertainties. All statements other than statements of historical facts contained in this quarterly report, including statements regarding our future results of operations, financial condition, business strategy and plans, strategic transformation plan, business models, and objectives of management for future operations, and statements regarding the benefits and timing of the roll-out of new products and technology, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions.
You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, and results of operations. The outcome of the events described in these forward-looking statements is subject to risks and uncertainties, including the factors described in “Part II, Item 1A. Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q. While we believe that such information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.
The forward-looking statements contained in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in or expressed by, and you should not place undue reliance on, our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments.
Additional Information
Unless the context otherwise requires, all references in this Quarterly Report on Form 10-Q to “we,” “us,” “our,” “our company,” and “Allbirds” refer to Allbirds, Inc. and its subsidiaries. The Allbirds design logo, “Allbirds,” and our other registered or common law trademarks, service marks, or trade names appearing in this Quarterly Report on Form 10-Q are the property of Allbirds, Inc. Other trade names, trademarks, and service marks used in this Quarterly Report on Form 10-Q are the property of their respective owners. Solely for convenience, we
have omitted the ® and ™ designations, as applicable, for the trademarks we name in this Quarterly Report on Form 10-Q.
We announce material information to the public through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls, our website (allbirds.com), the investor relations section of our website (ir.allbirds.com), our Instagram account (@allbirds), our X account (@allbirds), our LinkedIn account (linkedin.com/company/allbirds), and our Facebook page (@weareallbirds). We use these channels to communicate with investors and the public about our company, our products, and other matters. Therefore, we
i


encourage investors, the media and others interested in our company to review the information we make public in these locations, as such information could be deemed to be material information.
ii

Table of Contents
RISK FACTORS SUMMARY
Investing in our Class A common stock involves a high degree of risk because our business is subject to numerous risks and uncertainties, as more fully described in “Part II, Item 1A. Risk Factors” of this Quarterly Report on Form 10-Q. Below are some of these risks, any one of which could materially adversely affect our business, financial condition, results of operations, and prospects:
We may be unable to successfully execute on our strategic transformation plans, simplification initiatives, or our long-term growth strategy, including efforts to maintain or grow our current revenue and profit levels, reduce our costs or accurately forecast demand and supply for our products.
Our operating results may fluctuate significantly and our past operating results may not be a good indication of future performance.
Our efforts to transition our international go-to-market strategy from a direct model to a distributor model may not be successful and may negatively impact our operating results and brand value.
Economic uncertainty in our key markets may affect consumer purchases of discretionary items, which has affected and may continue to adversely affect demand for our products.
We have a significant amount of long-lived assets, which are assessed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable; additionally, we may never realize the full value of our long-lived assets, causing us to record material impairment charges.
If we are unable to maintain and enhance the value and reputation of our brand and/or counter any negative publicity, we may be unable to sell our products, which would harm our business and could materially adversely affect our financial condition and results of operations.
We have incurred significant net losses since inception and anticipate that we will continue to incur losses for the foreseeable future.
We operate in a highly competitive market and the size and resources of some of our competitors may allow them to compete more effectively than we can, which could result in a loss of our market share and a decrease in our net revenue and profitability.
Our focus on using sustainable high-quality materials and environmentally friendly manufacturing processes and supply chain practices may increase our cost of revenue and hinder our growth.
If we fail to attract new customers, retain existing customers, or maintain or increase sales to customers, our business, financial condition, results of operations, and growth prospects will be harmed.
Climate change and increased focus by governments, organizations, customers, and investors on sustainability issues, including those related to climate change and socially responsible activities, may adversely affect our reputation, business, and financial results.
If we are unable to anticipate product trends and consumer preferences, or we fail in our technical and materials innovation to successfully develop and introduce new high-quality products, we may not be able to maintain or increase our revenue and profits.
We utilize a range of marketing, advertising, and other initiatives to increase existing customers’ spend and to acquire new customers; if the costs of advertising or marketing increase, or if our initiatives fail to achieve their desired impact, we may be unable to grow the business profitably.
As a company that operates retail stores, we are subject to various risks, including commercial real estate and labor and employment risks; additionally, we may be unable to successfully open new store locations in existing or new geographies in a timely manner, if at all, or successfully implement and expand our third-party distribution and retail arrangements, which could harm our results of operations.
iii


Our business depends on our ability to maintain a strong community of engaged customers, including through the use of social media. We may be unable to maintain and enhance our brand if we experience negative publicity related to our marketing efforts or use of social media, or otherwise fail to meet our customers’ expectations.
Our financial results may be adversely affected if substantial investments in businesses and operations, including in our retail stores, fail to produce expected returns.
We are subject to risks related to our ESG activities and disclosures, and our reputation and brand could be harmed if we fail to meet our public sustainability targets and goals.
We are subject to risks related to our commitment to certain ESG criteria, including the SPO Framework.
Our reliance on suppliers and manufacturers to provide materials for and to produce our products could cause problems in our supply chain.
Our business is subject to the risk of manufacturer concentration.
Failure of our contractors or our licensees’ contractors to comply with our supplier code of conduct, contractual obligations, local laws, and other standards could harm our business.
The fluctuating cost of raw materials could increase our cost of revenue and cause our results of operations and financial condition to suffer.
We may fail to protect our intellectual property rights, our trademark and other proprietary rights may conflict with the rights of others, and we may not be able to acquire, use, or maintain our marks and domain names, any of which could harm our brand, business, financial condition, and results of operations.
If the technology-based systems that give our customers the ability to shop with us online do not function effectively, or we fail to comply with government regulations relating to the internet and eCommerce, our results of operations, as well as our ability to grow our digital business globally, could be materially adversely affected.
Our international operations expose us to various risks from foreign currency exchange rate fluctuations, tariffs or global trade wars, trade restrictions, and changing tax laws in the United States and elsewhere, among others.
We are subject to several unique risks as a result of our status as a Delaware public benefit corporation, or PBC, and certified B Corporation, or B Corp, including that our board of directors’ duty to balance various interests and our public benefit purpose may result in actions that do not maximize stockholder value.
The dual class structure of our common stock has the effect of concentrating voting control with our co-founders, Timothy Brown and Joseph Zwillinger, our directors, our principal stockholders, and their respective affiliates, which limits or precludes the ability of our other stockholders to influence corporate matters, including the election of directors and the approval of any change of control transaction.
If we fail to satisfy all applicable requirements of Nasdaq (including minimum closing bid price requirements), our Class A common stock could be delisted. which could adversely affect the market liquidity of our Class A common stock and cause the market price of our Class A common stock to decrease further.
If we are unable to adequately address these and other risks we face, our business may be harmed.
iv

Table of Contents
PART I—FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
ALLBIRDS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
(unaudited)
September 30,
2023
December 31,
2022
Assets
Current assets:
Cash and cash equivalents$132,483 $167,136 
Accounts receivable5,321 9,206 
Inventory79,933 116,796 
Prepaid expenses and other current assets18,012 15,796 
Total current assets235,749 308,934 
Property and equipment—net48,101 54,340 
Operating lease right-of-use assets89,586 91,232 
Other assets6,616 7,858 
Total assets$380,052 $462,364 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$12,580 $12,245 
Accrued expenses and other current liabilities20,148 23,448 
Current lease liabilities14,582 10,263 
Deferred revenue3,934 4,057 
Total current liabilities51,244 50,012 
Noncurrent liabilities:
Noncurrent lease liabilities92,420 95,583 
Other long-term liabilities
9  
Total noncurrent liabilities92,429 95,583 
Total liabilities$143,673 $145,595 
Commitments and contingencies (Note 16)
Stockholders’ equity:
Class A Common Stock, $0.0001 par value; 2,000,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 99,999,316 and 96,768,745 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
10 10 
Class B Common Stock, $0.0001 par value; 200,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 52,547,761 and 53,137,729 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively
5 5 
Additional paid-in capital575,833 559,106 
Accumulated other comprehensive loss(5,049)(3,611)
Accumulated deficit(334,420)(238,741)
Total stockholders’ equity236,379 316,769 
Total liabilities and stockholders’ equity$380,052 $462,364 
See accompanying notes to condensed consolidated financial statements.
1

ALLBIRDS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except share and per share amounts)
(unaudited)
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Net revenue$57,244 $72,651 $182,075 $213,588 
Cost of revenue32,351 40,120 105,218 120,263 
Gross profit24,893 32,531 76,857 93,325 
Operating expense:
Selling, general, and administrative expense43,545 44,644 132,516 125,106 
Marketing expense10,176 12,654 34,192 42,294 
Restructuring expense
1,234 747 5,514 747 
Total operating expense54,955 58,045 172,222 168,147 
Loss from operations(30,062)(25,514)(95,365)(74,822)
Loss from sales of businesses
(2,346) (2,346) 
Interest income (expense)1,120 (35)2,961 (107)
Other (expense) income(153)155 (298)393 
Loss before provision for income taxes(31,441)(25,394)(95,048)(74,536)
Income tax (provision) benefit
(134)153 (631)(1,953)
Net loss$(31,575)$(25,241)$(95,679)$(76,489)
Net loss per share data:
Net loss per share attributable to common stockholders, basic and diluted$(0.21)$(0.17)$(0.63)$(0.52)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted152,103,817149,267,269151,005,080148,481,459
Other comprehensive loss:
Foreign currency translation loss(906)(3,690)(1,438)(7,763)
Total comprehensive loss$(32,481)$(28,931)$(97,117)$(84,252)
See accompanying notes to condensed consolidated financial statements.
2

ALLBIRDS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except share amounts)
(unaudited)
Class A Common StockClass B Common StockAdditional Paid-In CapitalAccumulated Other Comprehensive LossAccumulated DeficitTotal Stockholders’ Equity
SharesAmountSharesAmount
BALANCE - June 30, 202294,397,696 $9 54,467,089 $6 $546,346 $(3,407)$(188,634)$354,320 
Exercise of stock options— — 121,576 — 323 — — 323 
Exercise of common stock warrants, net of shares withheld for exercise— — 3,750 — — — — — 
Vesting of common stock warrants— — — — — — — 
Vesting of restricted stock units364,914 — — — — — — — 
Repayment of non-recourse promissory note— — — — 539 — — 539 
Conversion of Class B shares into Class A common stock1,454,686 1 (1,454,686)(1)— — —  
Stock-based compensation— — — — 6,125 — — 6,125 
Comprehensive loss— — — — — (3,690)— (3,690)
Net loss— — — — — — (25,241)(25,241)
BALANCE - September 30, 202296,217,296 $10 53,137,729 $5 $553,333 $(7,097)$(213,876)$332,375 
Class A Common StockClass B Common StockAdditional Paid-In CapitalAccumulated Other Comprehensive LossAccumulated DeficitTotal Stockholders’ Equity
SharesAmountSharesAmount
BALANCE - June 30, 202398,818,595 $10 52,547,761 $5 $570,818 $(4,143)$(302,844)$263,846 
Exercise of stock options— — 405,986 — 78 — — 78 
Vesting of restricted stock units774,735 — — — — — — — 
Conversion of Class B shares into Class A common stock405,986 — (405,986)— — — — — 
Stock-based compensation— — — — 4,938 — — 4,938 
Comprehensive loss— — — — — (906)— (906)
Net loss— — — — — — (31,575)(31,575)
BALANCE - September 30, 202399,999,316 $10 52,547,761 $5 $575,833 $(5,049)$(334,420)$236,379 
See accompanying notes to condensed consolidated financial statements.
3

ALLBIRDS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except share amounts)
(unaudited)
Class A Common StockClass B Common StockAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal Stockholders’ Equity
SharesAmountSharesAmount
BALANCE - December 31, 202149,016,511 $5 98,038,941 $10 $533,709 $666 $(137,386)$397,004 
Exercise of stock options— — 1,734,516 — 2,586 — — 2,586 
Exercise of common stock warrants, net of shares withheld for exercise— — 25,717 — — — — — 
Vesting of common stock warrants— — — — 843 — — 843 
Vesting of restricted stock units367,414 — — — — — — — 
Repayment of non-recourse promissory note— — — — 539 — — 539 
Issuance of common stock under employee stock purchase plan171,926 — — — 823 — — 823 
Conversion of Class B shares into Class A common stock46,661,445 5 (46,661,445)(5)— — —  
Stock-based compensation— — — — 14,833 — — 14,833 
Comprehensive loss— — — — — (7,763)— (7,763)
Net loss— — — — — — (76,489)(76,489)
BALANCE - September 30, 202296,217,296 $10 53,137,729 $5 $553,333 $(7,097)$(213,876)$332,375 
Class A Common StockClass B Common StockAdditional Paid-In CapitalAccumulated Other Comprehensive Income (Loss)Accumulated DeficitTotal Stockholders’ Equity
SharesAmountSharesAmount
BALANCE - December 31, 202296,768,745 $10 53,137,729 $5 $559,106 $(3,611)$(238,741)$316,769 
Exercise of stock options— — 719,579 — 156 — — 156 
Vesting of restricted stock units1,690,736 — — — — — — — 
Issuance of common stock under employee stock purchase plan230,288 233 233 
Conversion of Class B shares into Class A common stock1,309,547 — (1,309,547)— — — — — 
Stock-based compensation— — — — 16,339 — — 16,339 
Comprehensive loss— — — — — (1,438)— (1,438)
Net loss— — — — — — (95,679)(95,679)
BALANCE - September 30, 202399,999,316 $10 52,547,761 $5 $575,833 $(5,049)$(334,420)$236,379 
See accompanying notes to condensed consolidated financial statements.
4

ALLBIRDS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Nine Months Ended September 30,
20232022
Cash flows from operating activities:
Net loss$(95,679)$(76,489)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization15,142 11,129 
Amortization of debt issuance costs37 37 
Stock-based compensation15,662 14,785 
Inventory write-down9,149 12,675 
Realized loss on equity investment84  
Loss from sales of businesses
2,376  
Changes in assets and liabilities:
Accounts receivable3,799 1,563 
Inventory23,090 (34,890)
Prepaid expenses and other current assets750 (1,939)
Operating lease right-of-use assets and current and noncurrent lease liabilities2,919  
Other assets (3,839)
Accounts payable and accrued expenses(2,783)(12,054)
Other long-term liabilities9 7,674 
Deferred revenue(53)(810)
Net cash used in operating activities(25,498)(82,158)
Cash flows from investing activities:
Purchase of property and equipment(9,657)(24,957)
Changes in security deposits758 (610)
Proceeds from equity investment166  
Net cash used in investing activities(8,733)(25,567)
Cash flows from financing activities:
Proceeds from the exercise of stock options516 2,738 
Taxes withheld and paid on employee stock awards(359)(152)
Proceeds from issuance of common stock under the employee stock purchase plan233 823 
Repayment of non-recourse promissory note 539 
Payments of deferred offering costs (744)
Net cash provided by financing activities390 3,204 
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash(804)(2,698)
Net decrease in cash, cash equivalents, and restricted cash(34,645)(107,219)
Cash, cash equivalents, and restricted cash—beginning of period167,767 288,576 
Cash, cash equivalents, and restricted cash—end of period$133,122 $181,357 
Supplemental disclosures of cash flow information:
Cash paid for interest$86 $63 
Cash paid for taxes$1,477 $1,366 
Noncash investing and financing activities:
Purchase of property and equipment included in accounts payable$30 $1,299 
Non-cash exercise of common stock warrants$ $35 
Stock-based compensation included in capitalized internal-use software$677 $892 
5

ALLBIRDS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Nine Months Ended September 30,
20232022
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents$132,483 $180,727 
Restricted cash included in prepaid expenses and other current assets639 630 
Total cash, cash equivalents, and restricted cash$133,122 $181,357 
See accompanying notes to condensed consolidated financial statements.
6

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1.Description of Business
Allbirds, Inc. (“Allbirds” and, together with its wholly owned subsidiaries, the “Company,” “we,” or “our”) was incorporated in the state of Delaware on May 6, 2015. Headquartered in San Francisco, California, Allbirds is a global lifestyle brand that innovates with naturally derived materials to make better footwear and apparel products in a better way, while treading lighter on our planet. The majority of our revenue is from sales directly to consumers via our digital and store channels.
Distributor Transition
In September 2023, we entered into agreements appointing exclusive distributors in South Korea and Canada. Under the distribution arrangements, each third-party distributor operates our existing websites and retail stores and sells products, purchased from us, through various distribution channels, including the stores and eCommerce platform, under our brand names in their respective country.
As part of the appointment, we entered into an asset purchase agreement with each distributor for the sale of certain net assets used in connection with the operations of our businesses in South Korea and Canada, respectively. Refer to Note 3, Business Combinations and Dispositions, for further details.
2.Significant Accounting Policies
Basis of Preparation—The accompanying unaudited condensed consolidated financial statements have been presented in U.S. dollars and prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial information. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes contained in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on March 10, 2023 (“Form 10-K”).
In our opinion, the accompanying unaudited condensed interim financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The condensed consolidated balance sheet as of December 31, 2022 has been derived from the audited financial statements at that date, but does not include all of the disclosures required by GAAP.
Certain monetary amounts, percentages, and other figures included elsewhere in these condensed consolidated financial statements and accompanying notes have been subject to rounding adjustments. As such, figures shown as totals in certain tables may not be the arithmetic aggregation of the figures that precede them, and figures expressed as percentages in the text may not total 100% or, as applicable, when aggregated may not be the arithmetic aggregation of the percentages that precede them.
Certain prior period reclassifications have been made in the condensed consolidated statements of operations and comprehensive loss to conform to the current period presentation. Specifically, for the three and nine months ended September 30, 2022, $0.7 million of selling, general and administrative expense was reclassified to restructuring expense in the condensed consolidated statements of operations and comprehensive loss. Such reclassification had no impact to our previously reported condensed consolidated balance sheet or condensed consolidated statement of cash flows.
Principles of Consolidation—The condensed consolidated financial statements include the accounts of Allbirds, Inc. and our wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates—The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial
7

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Risks and Uncertainties—We continue to monitor and respond to evolving developments about recent macroeconomic events, including elevated inflation, the U.S. Federal Reserve raising interest rates, bank failures, supply chain disruptions, fluctuations in currency exchange rates, geopolitical conflicts, and the COVID-19 pandemic, which have led to further economic uncertainty in the global economy. These macroeconomic conditions have had and are likely to continue to have adverse consequences on consumer spending, including the buying patterns of our customers and prospective customers. The conditions caused by the aforementioned recent macroeconomic events could affect the rate of consumer spending and could adversely affect demand for our products, lengthen our sales cycles, reduce the value of inventory, reduce expected spending from new customers, and affect our suppliers, all of which could adversely affect our business, results of operations, and financial condition.
As of the date of issuance of the financial statements we are not aware of any specific event or circumstance related to the aforementioned macroeconomic events that would require us to update our estimates or judgments or adjust the carrying value of our assets or liabilities. Actual results could differ from those estimates and any such differences may be material to the condensed consolidated financial statements.
Segments—Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by our chief operating decision maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. Prior to May 4, 2023, our CODMs were our co-Chief Executive Officers. On May 4, 2023, Timothy Brown, transitioned from his co-Chief Executive Officer role to Chief Innovation Officer, a non-executive role, and Joseph Zwillinger, our other co-Chief Executive Officer, was appointed our Chief Executive Officer. As a result, we performed an evaluation to determine our CODM. We determined that Joseph Zwillinger, Chief Executive Officer, was our CODM after May 4, 2023 and as of September 30, 2023.
We operate in one operating segment and one reportable segment, as the CODM reviews financial information presented on an aggregate basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. There was no change in our operating or reportable segments as a result of the change in CODM during the second quarter of 2023.
Foreign Currency Transactions—Our reporting currency is the U.S. dollar. The functional currency for each subsidiary included in these condensed consolidated financial statements that is domiciled outside of the United States is generally the applicable local currency of that country or the U.S. dollar. The translation of foreign currencies into U.S. dollars is performed for assets and liabilities using current foreign currency exchange rates in effect at the balance sheet date and for revenues and expense accounts using average foreign currency exchange rates during the period. Capital accounts are translated at historical foreign currency exchange rates. Translation gains and losses are included in stockholders’ equity as a component of accumulated other comprehensive income or loss. Adjustments that arise from foreign currency exchange rate changes on transactions denominated in a currency other than the functional currency are included in other income or expense on the condensed consolidated statements of operations and comprehensive loss.
Cash, Cash Equivalents, and Restricted Cash—We consider all highly liquid investments with an original maturity date of three months or less as cash equivalents. Cash and cash equivalents are comprised primarily of domestic and foreign bank accounts and money market funds. These cash and cash equivalents are valued based on Level 1 inputs, which consist of quoted prices in active markets. We place our cash and cash equivalents with several high credit quality financial institutions which, at times, may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits. We have not experienced any losses in such accounts and periodically evaluate the credit worthiness of the financial institutions. Our foreign bank accounts are not subject to FDIC insurance.
Restricted cash serves as collateral for a bond with the United States Customs and Border Protection (“CBP”), which allows us to take possession of our inventory before all formalities with the CBP are completed for imported
8

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
products. Restricted cash is included in prepaid expenses and other current assets on the condensed consolidated balance sheets.
Accounts Receivable—Accounts receivable consist primarily of amounts due from customers, which results from sales to customers including credit card deposits in transit at the balance sheet date, the majority of which are settled within two to three business days, and wholesale accounts receivable, which are settled per the terms of the sale. Wholesale account receivables were $2.3 million and $6.3 million as of September 30, 2023 and December 31, 2022, respectively. Credit card receivables were $2.1 million as of September 30, 2023 and December 31, 2022.
Inventory—Inventory consists of finished goods, stated at the lower of cost or net realizable value. We value our inventory using the weighted-average cost method and include product costs from our suppliers, freight, import duties and other landing costs.
We periodically review inventory and make provisions as necessary to appropriately value end of life, slow-moving, damaged, and excess inventory. To determine if the value of inventory requires a write-down, we estimate the net realizable value of inventory by considering current and anticipated demand, customer preferences and buying trends, and the age of the merchandise. Inventory write-downs are recognized as cost of revenue in the condensed consolidated statements of operations and comprehensive loss.
As of September 30, 2023 and December 31, 2022, we recorded an inventory reserve to reduce the value of our inventory by $11.4 million and $8.3 million, respectively, within inventory on the condensed consolidated balance sheets. Related to these inventory reserves, and also including actual shrinkage which is recorded throughout the year based on the results of physical inventory counts and donations, we recorded $1.1 million and $9.1 million as costs of revenue for the three and nine months ended September 30, 2023 and $2.7 million and $14.3 million for the three and nine months ended September 30, 2022, respectively.
Revenue Recognition—Our primary source of revenue is from sales of footwear and apparel products. We recognize revenue when control passes to the customer. This occurs at the time products are shipped to digital and wholesale customers, and at the point of sale for retail customers, which is when our performance obligation is satisfied. For the three and nine months ended September 30, 2023, we recognized $1.0 million and $3.0 million of revenue, respectively, that was deferred as of December 31, 2022, and for the three and nine months ended September 30, 2022, we recognized $1.0 million and $3.1 million, respectively, of revenue that was deferred as of December 31, 2021. As of September 30, 2023 and December 31, 2022, we had $0.4 million in cash collections of purchases via our digital channel which had not yet shipped, and $3.5 million and $3.6 million, respectively, in gift card liabilities included in deferred revenue in the condensed consolidated balance sheets. We had deferred revenue balances of $3.9 million and $3.4 million as of September 30, 2023 and September 30, 2022, respectively. The amounts as of September 30, 2023 are expected to be recognized over the next 12 months.
We record a reserve for estimated product returns, based upon historical return trends, in each reporting period as an offsetting decrease of net revenue, with an increase to our sales-refund reserve in accrued expenses. We have also recorded a related inventory returns receivable in prepaid expenses and other current assets, with an offsetting decrease to cost of revenue, as of September 30, 2023 and December 31, 2022 in the condensed consolidated balance sheets.
The following table disaggregates our net revenue by geographic area, where no individual foreign country contributed in excess of 10% of net revenue for the three and nine months ended September 30, 2023 and 2022. We recognized the following net revenue by geographic area based on the primary shipping address of the customer where the sale was made in our digital and wholesale channels, and based on the physical store location where the sale was made at a retail store:
Three Months Ended September 30,Nine Months Ended September 30,
(in thousands)2023202220232022
United States$43,671 $56,083 $135,555 $164,229 
International13,573 16,568 46,520 49,359 
Total net revenue$57,244 $72,651 $182,075 $213,588 
9

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Fair Value Measurements—Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 820, Fair Value Measurements, defines fair value, establishes a framework for measuring fair value under GAAP, and enhances disclosures about fair value measurements. It clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
Level 1—Observable inputs, such as quoted prices in active markets
Level 2—Inputs other than the quoted prices in active markets that are observable either directly or indirectly
Level 3—Unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions.
This hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. We record cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses at cost. The carrying values of these instruments approximate their fair value due to their short‐term maturities. We hold certain assets that are required to be measured at fair value on both a recurring and non-recurring basis, which are outlined in Note 9, Fair Value Measurements.
Impairment of Long-Lived Assets—We evaluate the recoverability of property and equipment, operating lease right-of-use assets, and other long-lived assets, including identifiable intangible assets with definite lives, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets are reviewed for recoverability at the lowest level in which there are identifiable cash flows (asset group). The asset group is typically at the country-level for store assets and the corporate-level for corporate assets. The carrying amount of a country asset group includes stores’ operating lease right-of-use assets and property and equipment, primarily leasehold improvements. Recoverability of assets held and used is measured by comparing the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds these estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount of the assets exceeds the fair value of the asset or asset group, based on estimated discounted net future cash flows. Assumptions used in these forecasts are consistent with internal planning, and include revenue growth rates, gross margins, and operating expense in relation to the current economic environment and our future expectations, competitive factors in our various markets, inflation, revenue trends and other relevant economic factors that may impact the asset group under evaluation.
There is uncertainty in the projected undiscounted future cash flows used in our impairment review analysis, which requires the use of estimates and assumptions. If our actual performance does not achieve our projections, or if the assumptions used change in the future, we may be required to recognize impairment charges in future periods, and any such charges could be material. We determined that a non-cash impairment charge was not necessary in the quarter ended September 30, 2023, based on our future cash flow estimates versus the net carrying value of our long-lived assets.
Restructuring Charges—In the first quarter of 2023, we announced a strategic transformation plan designed to improve our revenue trend, as well as improve capital efficiency and drive profitability in the business. As part of this effort, we have incurred professional fees, severance and other employee-related benefits, and other related
10

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
charges which are included within restructuring expense in the condensed consolidated statements of operations and comprehensive loss.
The following table presents a roll-forward of our restructuring charges, which are included within accrued expenses and other current liabilities in the condensed consolidated balance sheets:
(in thousands)Professional fees and other related chargesSeverance and other employee-related benefits
Balance as of June 30, 2023$89 $353 
Charges1,230 4 
Cash Payments(382)(357)
Balance as of September 30, 2023$937 $ 
(in thousands)Professional fees and other related chargesSeverance and other employee-related benefits
Balance as of December 31, 2022$ $ 
Charges5,158 357 
Cash Payments(4,221)(357)
Balance as of September 30, 2023$937 $ 
Emerging Growth Company—As an “emerging growth company,” the Jumpstart Our Business Startups Act, or JOBS Act, allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. For certain pronouncements, we have elected to use the adoption dates applicable to private companies. As a result, our financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective date for new or revised accounting standards that are applicable to public companies.
Recently Adopted Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13, Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses to estimate credit losses on certain types of financial instruments, including trade and account receivables, which may result in the earlier recognition of allowance for losses. The adoption of the guidance in the first quarter of 2023 did not have a material impact on our condensed consolidated financial statements and related disclosures as of and for the nine months ended September 30, 2023.
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to ease entities’ financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. The adoption of the guidance in the first quarter of 2023 did not have a material impact on our condensed consolidated financial statements and related disclosures as of and for the nine months ended September 30, 2023.
Recently Issued Accounting Pronouncements
In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain convertible instruments, amends the guidance on derivative scope exceptions for contracts in an entity's own equity, and modifies the guidance on diluted earnings per share calculations as a result of these changes. The guidance is effective for our fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The adoption of the guidance is not expected to have a material impact on our condensed consolidated financial statements and related disclosures.
11

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
3.Business Combinations and Dispositions
Dispositions
In September 2023, as part of our strategic transformation plan announced in March 2023, we sold our South Korean and Canadian businesses to unrelated third-parties. These sales did not qualify for accounting as discontinued operations under ASC 205, Presentation of Financial Statements.
South Korea
On September 5, 2023, we entered into an asset purchase agreement with an unrelated third party for the sale of certain net assets used in connection with the operation of our South Korean subsidiary, Allbirds Korea LLC. The net assets sold primarily included inventory and property and equipment related to our retail store lease, offset by sales return liabilities and gift card liabilities. As part of this transaction, we are to be paid consideration of $1.6 million, payable in three separate installments, first commencing within 60 days of the date of the sale and ending on March 31, 2024, recorded in other receivables within prepaid expenses and other current assets on our condensed consolidated balance sheet. Consideration received was less than the net book value of the transferred net assets of $1.9 million, resulting in a loss of $0.3 million, which was recorded in the condensed consolidated statement of operations and comprehensive loss for the three and nine months ended September 30, 2023.
Canada
On September 19, 2023, we entered into an asset purchase agreement with an unrelated third party for the sale of certain net assets used in connection with the operation of our Canadian subsidiary, Allbirds Canada, ULC. The net assets sold primarily include inventory and property and equipment related to our retail store leases, offset by sales return liabilities and gift card liabilities. As part of this transaction, we are to be paid a total consideration of $1.3 million, payable in four separate installments, commencing on November 15, 2023 and ending on March 15, 2024, recorded in other receivables within prepaid expenses and other current assets on our condensed consolidated balance sheet. Consideration received was less than the net book value of the transferred net assets of $3.3 million, resulting in a loss of $2.0 million, which was recorded in the condensed consolidated statement of operations and comprehensive loss for the three and nine months ended September 30, 2023.
Assets Held for Sale
As of September 30, 2023, we have not identified any property, equipment, and lease assets and liabilities that meet the criteria to be classified as “held for sale” under ASC 360, Property, Plant, and Equipment.
4.Inventory
Inventory consisted of the following as of September 30, 2023 and December 31, 2022:
(in thousands)September 30,
2023
December 31,
2022
Finished goods$91,371 $125,065 
Reserve to reduce inventories to net realizable value(11,438)(8,269)
Total inventory$79,933 $116,796 
12

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
5.Property and Equipment - Net
Property and equipment consisted of the following as of September 30, 2023 and December 31, 2022:
(in thousands)September 30,
2023
December 31,
2022
Leasehold improvements$39,830 $40,305 
Furniture and fixtures23,832 23,988 
Internal-use software28,110 23,393 
Machinery and equipment939 884 
Computers and equipment2,690 1,937 
Total property and equipment - gross95,401 90,507 
Less: accumulated depreciation and amortization(47,300)(36,167)
Total property and equipment - net$48,101 $54,340 
Depreciation and amortization expense for the three and nine months ended September 30, 2023 was $5.2 million and $15.3 million, respectively, and for three and nine months ended September 30, 2022 was $4.1 million and $11.2 million, respectively, recognized as selling, general, and administrative expense in the condensed consolidated statements of operations and comprehensive loss.
6.Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following as of September 30, 2023 and December 31, 2022:
(in thousands)September 30,
2023
December 31,
2022
Prepaid expenses$4,910 $6,283 
Inventory returns receivable714 1,090 
Security deposits499 463 
Taxes receivable7,304 6,420 
Other receivables3,946 908 
Restricted cash639 632 
Total prepaid expenses and other current assets$18,012 $15,796 
7.Other Assets
Other assets consisted of the following as of September 30, 2023 and December 31, 2022:
(in thousands)September 30,
2023
December 31,
2022
Investment in equity securities$2,000 $2,250 
Security deposits3,501 4,417 
Intangible assets94 133 
Debt issuance costs20 57 
Deferred tax assets1,001 1,001 
Total other assets$6,616 $7,858 
Investment in Equity Securities
On November 20, 2020, we entered into an agreement to make a minority equity investment of $2.0 million in Natural Fiber Welding, Inc. (“NFW”) in exchange for 201,207 shares of Series A-3 Preferred Stock. Our investment
13

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
is carried at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Throughout the year, we assess whether impairment indicators exist to trigger the performance of an impairment analysis. There were no impairment charges or observable price changes for the three and nine months ended September 30, 2023.
On November 22, 2021, we made a $0.3 million investment in NoHo ESG, Inc. (“NoHo ESG”) via a simple agreement for future equity (“SAFE”). Our investment was carried at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Throughout the year, we assess whether impairment indicators exist to trigger the performance of an impairment analysis. In April 2023, Noho ESG was dissolved. In accordance with the provisions of the SAFE, we were entitled to receive the entire amount of our investment. However, as a result of a shortfall of assets, we received a pro rata share of remaining assets, which included approximately $0.2 million in cash and rights to their intellectual property. Therefore, we recorded a realized loss on our investment of $0.1 million for the nine months ended September 30, 2023.
Definite-lived Intangible Assets
Intangible assets include intellectual property purchased from West Harbor Technologies, LLC (“West Harbor”) for $1.3 million, including transaction costs of $0.1 million, in January 2020. The intangible asset had an estimated useful life of 3 years, and was fully amortized as of March 31, 2023. We recorded amortization charges of $0.0 million for the three and nine months ended September 30, 2023, and $0.1 million and $0.3 million for the three and nine months ended September 30, 2022, respectively, which are recognized as selling, general, and administrative expense in the condensed consolidated statements of operations and comprehensive loss.
8.Accrued Expenses and Other Current Liabilities
Accrued expenses consisted of the following as of September 30, 2023 and December 31, 2022:
(in thousands)September 30,
2023
December 31,
2022
Sales-refund reserve$2,485 $4,534 
Taxes payable2,260 3,336 
Employee-related liabilities6,196 2,624 
Accrued expenses9,207 12,954 
Total accrued expenses and other current liabilities$20,148 $23,448 
14

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
9.Fair Value Measurements
Items Measured at Fair Value on a Recurring Basis
Money Market Funds—We hold cash in a U.S. treasury securities money market fund. The funds are classified as cash and cash equivalents on our condensed consolidated balance sheet as of September 30, 2023 and December 31, 2022 and represent Level 1 assets on the fair value hierarchy.
The following table summarizes, for assets measured at fair value, the respective fair value and classification by level of input within the fair value hierarchy as of September 30, 2023. We had no liabilities measured at fair value as of September 30, 2023.
September 30, 2023
(in thousands)Level 1Level 2Level 3Total
Assets
Money market funds$82,000 $ $ $82,000 
$82,000 $ $ $82,000 
Items Measured at Fair Value on a Non-Recurring Basis
Equity Investments—Our equity investments in NFW and Noho ESG represent non-marketable equity securities in privately held companies that do not have a readily determinable fair value and are accounted for under the measurement alternative in ASC 321. The investments are accounted for at cost and adjusted based on observable price changes from orderly transactions for identical or similar investments of the same issuer or impairment. During the three and nine months ended September 30, 2023 and 2022, there were no observable price changes or impairments for our NFW investment. We recognized a $0.1 million loss for our investment in Noho ESG during the nine months ended September 30, 2023, as described in Note 7. The carrying values of our investments were $2.0 million and $2.3 million as of September 30, 2023 and December 31, 2022, respectively.
10.Long-Term Debt
On February 20, 2019, we entered into a credit agreement with JPMorgan Chase Bank, N.A. (the “Original Credit Agreement”). The Original Credit Agreement was an asset-based loan, which provided for a revolving line of credit of up to $40.0 million and an optional accordion, which, if exercised, would have allowed us to increase the aggregate commitment by up to $35.0 million, subject to obtaining additional lender commitments and satisfying certain conditions. The Original Credit Agreement had a maturity date of February 20, 2024.
On April 17, 2023, we entered into an amendment to the Original Credit Agreement, which amended the terms of the Original Credit Agreement to, among other things, (i) increase the committed amount from $40.0 million to $50.0 million, (ii) increase the uncommitted incremental borrowing capacity from $35.0 million to $50.0 million, (iii) increase the interest rate margin by 0.50%, (iv) extend the maturity date from February 20, 2024 to April 17, 2026 and (v) provide that a Dominion Event Date (as defined therein) shall occur on any date on which Availability (as defined therein) is less than 25.0% of the Aggregate Revolving Commitments (as defined therein).
Interest on borrowings under the revolving credit facility accrued at a variable rate equal to (i) the Term Secured Overnight Financing Rate (“SOFR”), plus (ii) 0.10%, plus (ii) a specified spread of 1.25% or 1.50% dependent on the average quarterly revolver availability, calculated on the last day of each fiscal quarter being greater than 20% of the total revolver commitments or less than or equal to 20% of the total revolver commitments, respectively. The commitment fee under the Credit Agreement is 0.20% per annum on the average daily unused portion of each lender’s commitment. In addition, we are required to pay a fronting fee of 0.125% per annum on the average daily aggregate face amount of issued and outstanding letters of credit. Interest, commitment fees and fronting fees are payable monthly, in arrears.
The Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to us and our subsidiaries, including, among other things, restrictions on indebtedness,
15

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
liens, investments, mergers, dispositions, dividends and other distributions and a financial covenant that requires us to maintain a specified minimum fixed charge coverage ratio. In addition, the Credit Agreement contains certain customary events of default including, but not limited to, failure to pay interest, principal and fees or other amounts when due, material misrepresentations or misstatements in any representation or warranty, covenant defaults, certain cross defaults to other material indebtedness, certain judgment defaults and events of bankruptcy.
As of September 30, 2023 and December 31, 2022, there were no amounts outstanding under the Credit Agreement.
11.Stockholders’ Equity
As of September 30, 2023 and December 31, 2022, we were authorized to issue 2,220,000,000 shares of capital stock, comprised of 2,000,000,000 shares of Class A common stock, 200,000,000 shares of Class B common stock, and 20,000,000 shares of preferred stock. Each class had a par value of $0.0001 per share.
Preferred Stock
As of September 30, 2023 and December 31, 2022, there were no shares of preferred stock issued and outstanding. Our board of directors may, without further action by our stockholders, fix the rights, preferences, privileges, and restrictions of up to an aggregate of 20,000,000 shares of preferred stock in one or more series and authorize their issuance. The voting, dividend, and liquidation rights of the holders of common stock are subject to and qualified by the rights, powers, and preferences of the holders of preferred stock.
Common Stock
As of September 30, 2023 and December 31, 2022, we had two classes of common stock: Class A common stock and Class B common stock. Each class had a par value of $0.0001.
VotingHolders of Class A common stock are entitled to one vote per share on all matters to be voted upon by the stockholders, and holders of Class B common stock are entitled to 10 votes per share on all matters to be voted upon by the stockholders. The holders of our Class A common stock and Class B common stock generally vote together as a single class on all matters submitted to a vote of our stockholders, unless otherwise required by Delaware law or our amended and restated certificate of incorporation. Delaware law could require either holders of our Class A common stock or Class B common stock to vote separately as a single class in the following circumstances: (i) if we were to seek to amend our amended and restated certificate of incorporation to increase or decrease the par value of a class of our capital stock, then that class would be required to vote separately to approve the proposed amendment; and (ii) if we were to seek to amend our amended and restated certificate of incorporation in a manner that alters or changes the powers, preferences or special rights of a class of our capital stock in a manner that affected its holders adversely, then that class would be required to vote separately to approve the proposed amendment. As a result, in these limited instances, the holders of a majority of the Class A common stock could defeat an amendment to our amended and restated certificate of incorporation. Our amended and restated certificate of incorporation does not provide for cumulative voting for the election of directors.
DividendsHolders of Class A common stock and Class B common stock are entitled to ratably receive dividends if, as and when declared from time to time by our board of directors at its own discretion out of funds legally available for that purpose, after payment of dividends required to be paid on outstanding preferred stock, if any. Under Delaware law, we can only pay dividends either out of “surplus” or out of the current or the immediately preceding year’s net profits. Surplus is defined as the excess, if any, at any given time, of the total assets of a corporation over its total liabilities and statutory capital. The value of a corporation’s assets can be measured in a number of ways and may not necessarily equal their book value.
Right to Receive Liquidation DistributionsUpon our dissolution, liquidation or winding-up, the assets legally available for distribution to our stockholders are distributable ratably among the holders of our Class A common stock and Class B common stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding shares of preferred stock.
16

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
ConversionEach share of our Class B common stock is convertible at any time at the option of the holder into one share of our Class A common stock. Each share of our Class B common stock will convert automatically into one share of our Class A common stock upon any transfer, whether or not for value, except for (i) certain permitted transfers to entities, to the extent the transferor retains sole dispositive power and exclusive voting control with respect to the shares of Class B common stock, and (ii) certain other permitted transfers described in our amended and restated certificate of incorporation. In addition, if held by a natural person (including a natural person serving in a sole trustee capacity), each share of our Class B common stock will convert automatically into one share of our Class A common stock upon the death or incapacity of such natural person as described in our amended and restated certificate of incorporation. All outstanding shares of our Class B common stock will convert automatically into an equivalent number of shares of our Class A common stock upon the final conversion date, defined as the later of (a) the last trading day of the fiscal quarter immediately following the tenth anniversary of September 21, 2021 and (b) the date fixed by our board of directors that is no less than 61 days and no more than 180 days following the date on which the outstanding shares of Class B common stock first represent less than 10% of the aggregate number of the then outstanding shares of Class A common stock and Class B common stock (except if the final conversion date determined according to (a) or (b) would otherwise occur on or after the record date of any meeting of stockholders and before or at the time the vote at such meeting is taken, then the final conversion date shall instead be the last trading day of the fiscal quarter during which such vote was taken).
Other MattersThe Class A common stock and Class B common stock have no preemptive rights pursuant to the terms of our amended and restated certificate of incorporation and our amended and restated bylaws. There are no redemption or sinking fund provisions applicable to the Class A common stock and Class B common stock. All outstanding shares of our Class A common stock are fully paid and non-assessable.
Shares of common stock reserved for future issuance as of September 30, 2023 and December 31, 2022 consist of the following:
September 30,
2023
December 31,
2022
2015 Equity Incentive Plan:
Options issued and outstanding9,525,973 12,700,367 
Shares available for future option grants  
2021 Equity Incentive Plan:
Options issued and outstanding5,217,123 2,687,819 
Restricted stock units outstanding11,442,464 4,788,964 
Performance stock units outstanding525,108 787,660 
Shares available for future grants13,291,122 13,236,891 
2021 Employee Stock Purchase Plan:
Shares available for future grants5,359,971 4,091,248 
Total shares of common stock reserved for future issuance45,361,761 38,292,949 
12.Warrants
Common Stock Warrants
Through 2020, we issued warrants to purchase common stock to various third parties. The warrants were exercised in full in August 2022, and therefore, there were no common stock warrants outstanding as of September 30, 2023 and December 31, 2022. We recorded $0.0 million and $1.0 million of common stock warrant expense for the three and nine months ended September 30, 2022.
The following table is a summary of warrant activity for the three and nine months ended September 30, 2022:
17

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Date of issuanceJuly 2018
Outstanding at June 30, 20225,114 
Exercised during the three months ended September 30, 20225,114 
Outstanding at September 30, 2022 
Date of issuanceJuly 2018
Outstanding at December 31, 202130,684 
Exercised during the nine months ended September 30, 202230,684 
Outstanding at September 30, 2022 
13.Stock Transactions
On November 19, 2018, we received a promissory note from an employee in consideration for the early exercise of 220,000 shares of common stock options. The promissory note is secured by the underlying shares of common stock and, prior to amendment, bore interest at 2.86% per annum. In June 2023, the note was amended to no longer accrue interest after March 31, 2023 and to extend the maturity date to October 1, 2025. As of September 30, 2023, the promissory note remained outstanding.
Since the note is a limited recourse note, the note receivable is not reflected in our condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022.
14.Stock-Based Compensation
2015 Equity Incentive Plan
In 2015, we adopted the 2015 Equity Incentive Plan (the “2015 Plan”) that authorized the granting of options for shares of common stock. Our 2015 Plan provided for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit (“RSU”) awards, and other stock awards. The 2015 Plan was terminated in connection with the adoption of the 2021 Equity Incentive Plan (the “2021 Plan”) in November 2021 in connection with the initial public offering (“IPO”), and we will not grant any additional awards under the 2015 Plan. However, the 2015 Plan will continue to govern the terms and conditions of the outstanding awards previously granted thereunder.
2021 Equity Incentive Plan
In September 2021, our board of directors adopted, and our stockholders approved, the 2021 Plan, which became effective in connection with the IPO in November 2021. The 2021 Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock awards, RSU awards, performance awards, and other forms of equity compensation. In addition, the number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on January 1 of each year for a period of 10 years, beginning on January 1, 2022 and continuing through (and including) January 1, 2031, in an amount equal to 4% of the total number of share of our common stock (both Class A and Class B) outstanding on December 31 of the immediately preceding year, except that, before the date of any such increase, our board of directors may determine that the increase for such year will be a lesser number of shares. Additionally, to the extent that any stock options outstanding under the 2015 Plan expire, terminate prior to exercise, are not issued because the award is settled in cash, are forfeited because of the failure to vest, or are reacquired or withheld (or not issued) to satisfy a tax withholding obligation or the purchase or exercise price, if any, the shares of Class B common stock reserved for issuance pursuant to such equity awards will become available for issuance as shares of Class A common stock under the 2021 Plan. The maximum number of shares of our Class A common stock that may be issued on the exercise of incentive stock options under the 2021 Plan is 100,000,000 shares.
2021 Employee Stock Purchase Plan
In September 2021, our board of directors adopted, and our stockholders approved, the 2021 Employee Stock Purchase Plan (the “2021 ESPP”), which became effective in connection with the IPO in November 2021. The 2021
18

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
ESPP authorizes the issuance of shares of Class A common stock pursuant to purchase rights granted to employees. The number of shares of our Class A common stock reserved for issuance will automatically increase on January 1 of each year for a period of 10 years, beginning on January 1, 2022 and continuing through (and including) January 1, 2031, by the lesser of (1) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on December 31 of the immediately preceding year and (2) 2,850,000 shares, except that, before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth in clauses (1) and (2). The price at which Class A common stock is purchased under the 2021 ESPP is equal to 85% of the fair market value of a share of our Class A common stock on the first day of the offering period, or the date of purchase, whichever is lower. Offering periods are six months long and begin on November 3 and May 3 of each year.
Stock Options
A summary of the status of the 2015 Plan and 2021 Plan as of December 31, 2022 and September 30, 2023, and changes during the nine month period ended September 30, 2023, is presented below:
Options Outstanding
Number of OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term
(in years)
Aggregate Intrinsic Value
(in thousands)
Outstanding at December 31, 202215,388,186 $3.71 6.43$6,101 
Granted2,638,982 1.39 
Exercised(719,579)1.75 948 
Forfeited(1,080,938)3.83 
Cancelled(1,483,555)4.30 
Outstanding at September 30, 202314,743,096 3.38 6.361,878 
Vested and exercisable at September 30, 20239,122,606 3.61 4.821,878 
The weighted-average fair value of options granted during the three and nine months ended September 30, 2023 was $0.66 and $0.63, respectively, and for the three and nine months ended September 30, 2022 was $1.80 and $2.69, respectively. We calculated the fair value of each option using an expected volatility over the expected life of the option, which was estimated using the average volatility of comparable publicly traded companies. The expected life of options granted is based on the simplified method to estimate the expected life of the stock options, giving consideration to the contractual terms and vesting schedules.
The following weighted average assumptions were used for issuances during the three and nine months ended September 30, 2023 and 2022, for employees and non-employees:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Risk-free interest rate4.29 %2.86 %3.77 %2.78 %
Dividend yield    
Volatility43.12 %43.42 %42.43 %47.28 %
Expected lives (in years)6.136.136.045.92
2021 ESPP
The following table summarizes the weighted-average assumptions used in estimating the fair value of the 2021 ESPP grants for the following offering periods presented, using the Black Scholes option-pricing model:
19

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Offering Period - May 3, 2023 to November 2, 2023Offering Period - November 3, 2022 to May 2, 2023Offering Period - May 3, 2022 to November 2, 2022Offering Period - November 3, 2021 to May 2, 2022
Risk-free interest rate5.08 %4.44 %2.97 %1.63 %
Dividend yield    
Volatility45.59 %43.42 %47.15 %63.00 %
Expected lives (years)0.50.50.50.5
RSUs
After completion of the IPO in November 2021, we began granting RSUs to certain employees. The RSUs granted have service-based vesting conditions. The service-based vesting condition for awards to new employees is typically satisfied over four years, with a cliff vesting period of one year and continued vesting quarterly thereafter. The service-based vesting condition for refresh grants of RSUs to existing employees is typically satisfied over three years with vesting occurring quarterly, subject to the employees’ continued service to us. RSUs and the related stock-based compensation are recognized on a straight-line basis over the requisite service period.
RSU activity during the nine months ended September 30, 2023 was as follows:
Number of SharesWeighted-Average Grant Date Fair Value per Share
Unvested at December 31, 2022
4,788,964 $4.86 
Granted10,308,183 1.65 
Vested(1,690,736)4.16 
Forfeited(1,963,947)3.92 
Unvested at September 30, 2023
11,442,464 $2.23 
Performance Stock Units
In May 2022, we granted a target amount of 0.8 million RSUs with market-based and service-based vesting conditions (“PSUs”) to certain executives. The market vesting criteria is based on achievement of certain total shareholder return (“TSR”) results relative to the S&P Total Market Consumer Discretionary Index (the “Index”) during a one-year, two-year, and three-year performance period, respectively, beginning on June 1, 2022, and ending on May 31, 2025. The market condition allows for a range of vesting from 0% to 150% of the target amount, depending on the relative TSR achieved by us against the Index. In addition to the market condition, these PSUs are subject to the continuing service of the executives and vest in three equal annual installments. The fair value of PSUs is measured on the grant date using a Monte Carlo simulation model. Each of the three performance periods is considered an individual tranche of the award (referred to as “Tranche 1,” “Tranche 2” and “Tranche 3,”respectively).
Number of SharesGrant Date Fair Value per ShareRequisite Service Period
Tranche 1262,553 $4.77 June 1, 2022 - May 31, 2023
Tranche 2262,553 $5.16 June 1, 2022 - May 31, 2024
Tranche 3262,554 $5.41 June 1, 2022 - May 31, 2025
The total grant date fair value of the awards was determined to be $4.0 million, with each tranche of the awards representing $1.3 million, $1.4 million, and $1.4 million of the total expense, respectively. Stock-based compensation expense related to PSUs is recognized on a straight-line basis over their requisite service periods, regardless of whether the market condition is ultimately satisfied. Stock-based compensation expense is not reversed if the achievement of the market condition does not occur. We recognized stock-based compensation expense of
20

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
$0.4 million and $1.3 million for the three and nine months ended September 30, 2023, respectively, and $0.6 million and $0.8 million for the three and nine months ended September 30, 2022, respectively, as selling, general and administrative expense in the condensed consolidated statements of operations and comprehensive loss related to these awards. We recognized no stock-based compensation expense for these awards prior to May 2022.
PSU activity during the nine months ended September 30, 2023 was as follows:
Target Number of SharesWeighted-Average Grant Date Fair Value per Share
Unvested at December 31, 2022
787,660 $5.11 
Granted  
Vested  
Forfeited(262,552)$4.77 
Unvested at September 30, 2023
525,108 $5.29 
Stock-Based Compensation Expense
Stock-based compensation expense, recognized as selling, general, and administrative expense in the condensed consolidated statements of operations and comprehensive loss for the three and nine months ended September 30, 2023 and 2022, was comprised of the following:
Three Months Ended September 30,Nine Months Ended September 30,
(in thousands)2023202220232022
Stock-based compensation, net of amounts capitalized$4,690 $5,793 15,662 13,942 
Capitalized stock-based compensation248 333 677 892 
Total stock-based compensation$4,938 $6,126 $16,339 $14,834 
As of September 30, 2023, there was approximately $9.2 million of total unrecognized compensation cost related to unvested stock options granted under both equity incentive plans, which is expected to be recognized over the weighted-average remaining vesting period of approximately 2.91 years. There was approximately $22.0 million of total unrecognized compensation cost related to outstanding unvested RSUs under the 2021 Plan, which is expected to be recognized over the weighted-average remaining vesting period of approximately 2.53 years. There was approximately $1.4 million of total unrecognized compensation cost related to outstanding unvested PSUs under the 2021 Plan, which is expected to be recognized over the weighted-average remaining vesting period of approximately 1.67 years.
15.Income Taxes
Income tax provision (benefit) was $0.1 million and $0.6 million for the three and nine months ended September 30, 2023, respectively, and was ($0.2) million and $2.0 million for the three and nine months ended September 30, 2022, respectively. The effective tax rate for the three and nine months ended September 30, 2023 was 0.4% and 0.7%, respectively, and was (0.6)% and 2.6% for the three and nine months ended September 30, 2022, respectively. The changes in expense for income taxes and effective tax rate is primarily due to mix of income by geography.
Our tax provision for income taxes for interim periods is determined using an estimate of our annual effective tax rate, adjusted for discrete items, if any. Each quarter, we update our estimate of the annual effective tax rate and make a year-to-date adjustment to the provision.
As of September 30, 2023, we are subject to examination by various tax authorities for 2016 through 2022. During the three and nine months ended September 30, 2023, there was no material change to our uncertain tax positions. We do not expect our unrecognized tax positions to change significantly over the next twelve months.
21

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
16.Commitments and Contingencies
Legal Proceedings
We are subject to various claims and legal proceedings that arise in the ordinary course of our business activities. Although the outcome of any legal proceedings cannot be predicted with certainty, as of September 30, 2023, our ultimate liability, if any, is not expected to have a material effect on our financial position or operations.
On April 13, 2023, and on May 16, 2023, we and certain of our executive officers and directors were named as defendants in two substantially similar securities class action lawsuits, captioned Shnayder v. Allbirds, Inc., et al., Case No. 23-cv-01811-AMO and Delgado v. Allbirds, Inc., et al., Case No. 23-cv-02372-AMO, filed in the United States District Court for the Northern District of California. These lawsuits allege that we violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 and U.S. Securities and Exchange Commission Rule 10b-5, 17 C.F.R. § 240.10b-5, promulgated thereunder, and Sections 11 and 15 of the Securities Act of 1933 by making materially false and/or misleading statements about our business, operations and prospects. The plaintiffs seek damages in an unspecified amount. On July 25, 2023, the court entered an order consolidating the two cases, appointing lead plaintiffs, and approving lead plaintiffs’ selection of lead counsel. On September 15, 2023, lead plaintiffs filed a consolidated amended complaint against the same group of defendants and asserting the same claims. We filed a motion to dismiss the consolidated complaint on November 3, 2023. We intend to vigorously defend against this lawsuit.
On October 3, 2023, we and certain of our executive officers and directors were named as defendants in a shareholder derivative suit, captioned Park v. Zwillinger, et al., Case No. 23-cv-01092-CFC, filed in the United States District Court for the District of Delaware. This lawsuit alleges violations of Section 14(a) of the Exchange Act, contribution under Section 21D of the Exchange Act, breach of fiduciary duties, and aiding and abetting based on allegations that are substantially similar to those asserted in the securities class action. On October 13, 2023, we and certain of our past and current executive officers and directors were named as defendants in a substantially similar shareholder derivative suit, captioned Junker v. Zwillinger, et al., Case No. 23-cv-01152-CFC, filed in the United States District Court for the District of Delaware. This lawsuit alleges breach of fiduciary duties, unjust enrichment, violations of Section 10(b) of the Exchange Act, contribution under Section 11(f) of the Securities Act and Section 21D of the Exchange Act, and waste of corporate assets based on allegations that are substantially similar to those asserted in the securities class action. We intend to vigorously defend against these lawsuits.
17.Leases
We lease various office and retail spaces under non-cancelable operating leases with various expiration dates through fiscal 2034, certain of which contain renewal provisions. These renewal provisions are not reasonably certain to be exercised and therefore are not factored into the determination of lease payments. We have no lease agreements that are classified as finance leases.
The components of lease costs, recognized as selling, general, and administrative expense in the condensed consolidated statements of operations and comprehensive loss, along with the weighted-average lease term and weighted-average discount rate for operating leases, are as follows:
22

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Three Months Ended September 30,Nine Months Ended September 30,
(in thousands, except for lease term and discount rate)2023202220232022
Operating lease costs$4,666 $4,397 $13,884 $11,945 
Variable lease costs56 55 168 169 
Short-term lease costs3 187 73 444 
Sublease income(57) (110) 
Total lease costs$4,668 $4,639 $14,015 $12,558 
September 30,
2023
September 30,
2022
Weighted-average remaining lease term (in years)7.293.97
Weighted-average discount rate5.55 %4.32 %
Supplemental cash flow information related to operating leases are as follows:

Three Months Ended September 30,Nine Months Ended September 30,
(in thousands)2023202220232022
Cash paid for amounts included in the measurement of operating lease liabilities$4,246 $3,850 $10,371 $10,207 
Right-of-use assets obtained in exchange for new operating lease liabilities 24 8,201 8,480 33,514 
Future minimum lease payments under non-cancelable operating leases with initial lease terms in excess of one year, included in our lease liabilities as of September 30, 2023, are as follows:
(in thousands)Operating Lease Payments (1)
Fiscal year ended December 31,
2023$5,069 
202419,755 
202519,558 
202618,088 
2027 and after69,983 
Total undiscounted operating lease payments$132,453 
Less: imputed discount25,450 
Total operating lease liabilities $107,002 
___________
(1) 2023 amounts as shown above are net of cash inflows for tenant improvement allowances expected to be received during the year.
18.Net Loss Per Share
We compute net loss per share using the two-class method required for participating securities and multiple classes of common stock. The two-class method requires net income or loss be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income or loss for the period had been distributed. The rights, including the liquidation and dividend rights and sharing of losses of the Class A common stock and Class B common stock are identical, other than voting, transfer, and conversion rights. As the liquidation and dividend rights and sharing of losses are identical, the undistributed earnings are allocated on a
23

ALLBIRDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
proportionate basis and the resulting net loss per share attributed to common stockholders will, therefore, be the same for both Class A and Class B common stock on an individual or combined basis.
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the three and nine months ended September 30, 2023 and 2022:
Three Months Ended September 30,Nine Months Ended September 30,
(in thousands, except share and per share data)2023202220232022
Numerator:
Net loss attributable to common stockholders$(31,575)$(25,241)$(95,679)$(76,489)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted152,103,817149,267,269151,005,080148,481,459
Net loss per share attributable to common stockholders, basic and diluted$(0.21)$(0.17)$(0.63)$(0.52)
The following shares of preferred stock and common stock were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive:
September 30,
2023
September 30,
2022
Outstanding stock options14,743,096 15,590,268 
Common stock warrants 0
2021 ESPP43,692 53,803 
RSUs11,442,464 5,081,676 
PSUs525,108 787,660 
Total anti-dilutive securities26,754,360 21,513,407 
19.Benefit Plan
We sponsor a 401(k) defined contribution plan covering eligible employees who elect to participate. We are allowed to make discretionary profit sharing and matching contributions as defined in the plan and as approved by our board of directors. No discretionary profit-sharing contributions were made for the three and nine months ended September 30, 2023 and 2022. We made $0.3 million and $1.1 million in matching contributions for the three and nine months ended September 30, 2023, respectively, and $0.4 million and $1.0 million for the three and nine months ended September 30, 2022, respectively. We have no intention to terminate the plan.
20.Subsequent Events
We have evaluated events occurring through November 8, 2023, the date the condensed consolidated financial statements were available for issuance, and have determined there are no subsequent events that require disclosure in these condensed consolidated financial statements.
24

Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. As discussed in the section titled “Special Note Regarding Forward-Looking Statements,” the following discussion and analysis contains forward-looking statements that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section titled “Risk Factors” included under Part II, Item 1A below.
Overview
Allbirds is a global lifestyle brand that innovates with naturally derived materials to make better footwear and apparel products in a better way, while treading lighter on our planet.
We began our journey in 2015 with three fundamental beliefs about the emerging generation of consumers: first, these consumers recognize that climate change is an existential threat to the human race; second, these consumers connect their purchase decisions with their impact on the planet, demanding more from businesses; and third, these consumers do not want to compromise between looking good, feeling good, and doing good. We became a public benefit corporation, or PBC, under Delaware law and earned our B Corporation, or B Corp, certification in 2016, codifying how we take into account the impact our actions have on all of our stakeholders, including the environment, our flock of employees, communities, consumers, and investors.
We generate our revenue through a digitally-led vertical retail distribution strategy. We generally market directly to consumers via our localized multilingual digital platform and our physical footprint of 60 stores as of September 30, 2023. In addition to our direct business, we selectively partner with third-parties, including wholesalers and distributors, to sell our products through their channels, which helps us reach more consumers and increase brand awareness.
Designing and creating products using innovative, sustainable materials is a challenging process for both us as well as our supply chain partners. We have invested time and resources to train our manufacturers to use our natural materials, which we believe makes it difficult to replicate our novel manufacturing processes at our product quality.
Recent Financial Performance
Net revenue decreased by 21.2% and 14.8% for the three and nine months ended September 30, 2023, respectively, as compared to the same periods in 2022.
Gross margin was 43.5% and 42.2% for the three and nine months ended September 30, 2023, respectively, as compared to 44.8% and 43.7% for the same periods in 2022.
We reported net losses of $31.6 million and $95.7 million for the three and nine months ended September 30, 2023, respectively, as compared to $25.2 million and $76.5 million for the same periods in 2022.
We reported adjusted EBITDA losses of $19.0 million and $58.9 million for the three and nine months ended September 30, 2023, respectively, as compared to losses of $14.8 million and $47.9 million for the same periods in 20221.
Adjusted EBITDA is a financial measure that is not calculated in accordance with generally accepted accounting principles in the United States, or GAAP. See the section titled “Non-GAAP Financial Measures” below
1 We are no longer excluding the revenue and cost of revenue impact associated with the inventory optimization related to the previously announced discontinuation of our first generation apparel business, the Simplification Initiatives, from Adjusted EBITDA. The impact of this change to our adjusted EBITDA for the three and nine months ended September 30, 2022 is an increase to Adjusted EBITDA loss of $11.6 million.
25

Table of Contents
for the definition of adjusted EBITDA, as well as a reconciliation of non-GAAP financial measures to their most directly comparable GAAP financial measures.
Recent Developments
Distributor Transition
In September 2023, we entered into agreements appointing exclusive distributors in South Korea and Canada. These distributors oversee the distribution of our products, purchased from us, across eCommerce, brick and mortar, and wholesale channels in their respective territories and are required to allocate dedicated brand and marketing resources to their operations for us.
As part of their appointment, we entered into an asset purchase agreement with each distributor for the sale of certain net assets used in connection with the operations of our businesses in South Korea and Canada, respectively.
The distributor model in these regions will result in a reduction to revenue and gross profit in the near term, because the selling price to distributors will be below the full price we have historically sold to our direct consumers. Because we expect lower operating expenses as compared to the direct model, we also expect these transitions to improve adjusted EBITDA profitability and inventory efficiency, while also helping to reduce overall complexity in our business.
March 2023 Strategic Transformation
In March 2023, we announced the implementation of a strategic transformation plan designed to reignite growth in the coming years, as well as improve capital efficiency, and drive profitability. The plan focuses on four key areas.
Our product and brand initiatives include increasing focus on our core franchises, through a concentration on comfort and quality and better commercialization of our innovative materials, as well as a highly-focused brand strategy that reconnects with core consumers. We expect these initiatives to begin to impact the business in 2024.
Our store-based distribution initiatives in the United States include optimizing our existing store fleet and selectively expanding our third party distribution channels. Store optimization will include slowing the pace of new store openings and investing in corporate and retail store talent and store marketing. As of July 2023, we had completed all planned new store openings and we continue to evaluate ways to optimize our existing store fleet.
Our international go-to-market strategy initiative encompasses evaluating ways to reduce complexity and grow internationally in a cost- and capital-efficient manner. In September 2023, we signed distribution agreements with South Korean distributor and a Canadian distributor with respect to each particular country, and we are continuing to evaluate our international go-to-market strategy. We may continue to enter into similar distribution arrangements with third parties in other international markets, which we expect would have impacts to both our short and long term results of operations. Subsequent to the close of the third quarter, Allbirds entered into a non-binding letter of intent with a distributor partner in Japan and a non-bin